← All organizations

Xentria, Inc.

For profit

Also known as: Xentria, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2025

Timeline

2020s

Jun 1, 2020
Xentria, Inc.— Founded

Drugs by trial phase (5 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

denosumab

Phase 2 (1 own, 0 via acquisition)

xtmab-16

Phase 1 (3 own, 0 via acquisition)

Recent trials (8)

NCT06504966Lead sponsorPhase 3Oct 31, 2025
NCT07165652Lead sponsorPhase 1Oct 13, 2025
NCT06627478Lead sponsorPhase 1Oct 29, 2024
NCT06492226Lead sponsorPhase 1Jul 30, 2024
NCT06310824Lead sponsorPhase 1Jun 5, 2024
NCT06169397Lead sponsorPhase 2Jan 31, 2024
NCT05890729Lead sponsorPhase 1/Phase 2Nov 10, 2023
NCT04971395Lead sponsorPhase 1Jun 25, 2021

Details

Founded: Chicago, IL, US Jun 1, 2020
Last known activity: Oct 31, 2025